Neurofilament Light Chain (Nfl) Level in Serum as a Suitable In Vivo Biomarker for Axonal Damage in a Murine Viral Model of Multiple Sclerosis
Journal of Cellular and Molecular Medicine · 2026-08 · 30 (15)
DOI: 10.1111/jcmm.71304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.07.2026. Verfasst von A Segna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany. Hauptthemen laut MEDLINE: Axons, Multiple Sclerosis, Neurofilament Proteins. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Studienstiftung des Deutschen Volkes, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Neurofilament light chain (Nfl) is a protein of the cytoskeleton predominantly found in large calibre myelinated axons and a suitable in vivo biomarker for monitoring neurodegenerative processes. Axonal damage results in Nfl release into the cerebrospinal fluid and the blood stream. Axonal damage is a frequent finding in Theiler's murine encephalomyelitis virus (TMEV)‐infected SJL mice, a viral model for multiple sclerosis. Following the hypothesis that TMEV‐associated axonal damage is reflected by serum Nfl (sNfl) levels, histopathological findings were compared with sNfl levels at 7, 14, 42 and 147/85 days post infection (dpi) in TMEV‐susceptible SJL and ‐resistant C57BL/6 mice. Axonal damage was evaluated by immunohistochemistry for β‐amyloid precursor protein (βAPP) and synaptophysin (syn). Both markers were significantly increased at 42 and 85 dpi in the spinal cord of SJL mice, whereas no axonopathy was observed in the spinal cord of C57BL/6 mice. Similarly, significantly increased sNfl values were only observed in SJL mice at 42 and 85 dpi but not in C57BL/6 mice. Results show a positive correlation between histochemically detected axonal damage and sNfl in TMEV‐infected SJL mice. Thus, sNfl represents a potential marker for in vivo monitoring of axonal damage in this animal model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
- Center for Systems Neuroscience, Hannover, Germany.
- Department of Biometry, Epidemiology and Data Processing, University of Veterinary Medicine Hannover, Hannover, Germany.
- Idorsia Pharmaceuticals Ldt., Allschwill, Switzerland.
- Institute of Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
ORCID-Profile: A Segna, R Wannemacher, K Rohn
Förderung
- Studienstiftung des Deutschen Volkes
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Segna, A., Wannemacher, R., Rohn, K., Sippel, V., Steiner, M. A., Lühder, F., Flügel, A., Baumgärtner, W., & Hülskötter, K. (2026). Neurofilament Light Chain (Nfl) Level in Serum as a Suitable In Vivo Biomarker for Axonal Damage in a Murine Viral Model of Multiple Sclerosis. Journal of Cellular and Molecular Medicine, 30(15). https://doi.org/10.1111/jcmm.71304
Vancouver
Segna A, Wannemacher R, Rohn K, Sippel V, Steiner MA, Lühder F, et al. Neurofilament Light Chain (Nfl) Level in Serum as a Suitable In Vivo Biomarker for Axonal Damage in a Murine Viral Model of Multiple Sclerosis. Journal of Cellular and Molecular Medicine. 2026;30(15). doi:10.1111/jcmm.71304
BibTeX
@article{Segna2026,
author = {Segna, A and Wannemacher, R and Rohn, K and Sippel, V and Steiner, M A and Lühder, F and Flügel, A and Baumgärtner, W and Hülskötter, K},
title = {Neurofilament Light Chain (Nfl) Level in Serum as a Suitable In Vivo Biomarker for Axonal Damage in a Murine Viral Model of Multiple Sclerosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {15},
doi = {10.1111/jcmm.71304}
}
EUVIMED